EA201290610A1 - Сульфоновые соединения в качестве лигандов 5-htрецептора - Google Patents
Сульфоновые соединения в качестве лигандов 5-htрецептораInfo
- Publication number
- EA201290610A1 EA201290610A1 EA201290610A EA201290610A EA201290610A1 EA 201290610 A1 EA201290610 A1 EA 201290610A1 EA 201290610 A EA201290610 A EA 201290610A EA 201290610 A EA201290610 A EA 201290610A EA 201290610 A1 EA201290610 A1 EA 201290610A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- ligands
- htreceptor
- polymorphs
- tautomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Abstract
Настоящее изобретение относится к новым сульфоновым соединениям в качестве лигандов 5-НТрецептора формулы (I) и их производным, пролекарствам, таутомерам, стереоизомерам, полиморфам, сольватам, гидратам, метаболитам, N-оксидам, фармацевтически приемлемым солям и содержащим их композициям. Настоящее изобретение также относится к способу получения упомянутых выше новых соединений и их производных, пролекарств, таутомеров, стереоизомеров, полиморфов, сольватов, гидратов, метаболитов, N-оксидов, фармацевтически приемлемых солей и содержащих их композиций. Данные соединения являются пригодными для лечения/предотвращения различных заболеваний, которые связаны с функциями 5-НТрецептора.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN18CH2010 | 2010-01-05 | ||
PCT/IN2010/000176 WO2011083487A1 (en) | 2010-01-05 | 2010-03-24 | Sulfone compounds as 5-ht6 receptor ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201290610A1 true EA201290610A1 (ru) | 2013-02-28 |
EA022043B1 EA022043B1 (ru) | 2015-10-30 |
Family
ID=42941911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201290610A EA022043B1 (ru) | 2010-01-05 | 2010-03-24 | Сульфоновые соединения в качестве лигандов 5-htрецептора |
Country Status (18)
Country | Link |
---|---|
US (1) | US9018231B2 (ru) |
EP (1) | EP2521714B1 (ru) |
JP (1) | JP5628937B2 (ru) |
KR (1) | KR101463190B1 (ru) |
CN (1) | CN102869647B (ru) |
AU (1) | AU2010340745B2 (ru) |
BR (1) | BR112012016526A2 (ru) |
CA (1) | CA2786072C (ru) |
DK (1) | DK2521714T3 (ru) |
EA (1) | EA022043B1 (ru) |
ES (1) | ES2552463T3 (ru) |
HK (1) | HK1176619A1 (ru) |
IL (1) | IL220709A (ru) |
MX (1) | MX2012007783A (ru) |
NZ (1) | NZ601284A (ru) |
SG (1) | SG181992A1 (ru) |
WO (1) | WO2011083487A1 (ru) |
ZA (1) | ZA201205253B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013055386A2 (en) | 2011-10-03 | 2013-04-18 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
TWI623520B (zh) * | 2012-12-12 | 2018-05-11 | 德商拜耳作物科學股份有限公司 | 製備雙(3-胺基苯基)二硫化物及3-胺基硫醇之方法 |
US20160038484A1 (en) * | 2013-04-03 | 2016-02-11 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
CA2953004C (en) | 2014-07-08 | 2023-02-21 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
MA45002B1 (fr) * | 2016-05-18 | 2020-10-28 | Suven Life Sciences Ltd | Triple combinaison d'antagonistes purs du récepteurs 5-ht6, d'inhibiteurs de l'acétylcholinestérase et d'antagonistes du récepteur nmda |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2376A1 (fr) | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
WO1999002502A2 (en) | 1997-07-11 | 1999-01-21 | Smithkline Beecham Plc | Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
GB9801392D0 (en) | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
GB9803411D0 (en) | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
DE69937372T2 (de) | 1999-04-21 | 2008-06-26 | Nps Allelix Corp., Mississauga | Piperidin-indol derivate mit 5-ht6 affinität |
GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
US20040039044A1 (en) * | 2000-10-30 | 2004-02-26 | Yuanjin Rui | Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
CN1275967C (zh) | 2001-01-30 | 2006-09-20 | 伊莱利利公司 | 用作5-ht6受体拮抗剂的苯磺酸吲哚-5-基酯 |
WO2002098878A1 (en) | 2001-02-08 | 2002-12-12 | Memory Pharmaceuticals Corporation | Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
JP4187642B2 (ja) | 2001-06-07 | 2008-11-26 | エフ.ホフマン−ラ ロシュ アーゲー | 5−ht6受容体親和性を有する新規インドール誘導体 |
JP2005528587A (ja) | 2002-02-01 | 2005-09-22 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 新規ヒト5−ht6受容体に関連する疾患のための診断用および治療用物質 |
JP2005522432A (ja) | 2002-02-05 | 2005-07-28 | グラクソ グループ リミテッド | ニューロン成長の促進方法 |
PL209872B1 (pl) | 2002-03-27 | 2011-10-31 | Glaxo Group Ltd | Pochodna chinolinowa, sposób jej wytwarzania i jej zastosowanie oraz zawierająca ją farmaceutyczna kompozycja |
KR100818508B1 (ko) | 2002-11-28 | 2008-03-31 | 수벤 라이프 사이언시스 리미티드 | 세로토닌 수용체 친화력을 가지는 엔-아릴술포닐-3-치환인돌, 그 제조방법 및 그를 포함하는 약제학적 조성물 |
WO2004048331A1 (en) | 2002-11-28 | 2004-06-10 | Suven Life Sciences Limited | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands |
ES2425143T3 (es) | 2002-11-28 | 2013-10-11 | Suven Life Sciences Limited | N-Arilsulfonil-3-aminoalcoxiindoles |
WO2004108671A1 (en) | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
WO2005066157A1 (en) | 2004-01-02 | 2005-07-21 | Suven Life Sciences | 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
WO2007020653A1 (en) | 2005-08-12 | 2007-02-22 | Suven Life Sciences Limited | Thioether derivatives as functional 5-ht6 ligands |
DK1919896T3 (da) * | 2005-08-12 | 2010-04-19 | Suven Life Sciences Ltd | Aminoarylsulfonamidderivater, som funktionelle 5-HT6-ligander |
WO2007046112A1 (en) | 2005-10-19 | 2007-04-26 | Suven Life Sciences Inc. | Arylthioether tryptamine derivatives as functional 5-ht6 ligands |
WO2007138611A1 (en) | 2006-05-30 | 2007-12-06 | Suven Life Sciences Limited | 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands |
-
2010
- 2010-03-24 WO PCT/IN2010/000176 patent/WO2011083487A1/en active Application Filing
- 2010-03-24 CA CA2786072A patent/CA2786072C/en not_active Expired - Fee Related
- 2010-03-24 NZ NZ601284A patent/NZ601284A/en not_active IP Right Cessation
- 2010-03-24 CN CN201080065143.0A patent/CN102869647B/zh not_active Expired - Fee Related
- 2010-03-24 EA EA201290610A patent/EA022043B1/ru not_active IP Right Cessation
- 2010-03-24 US US13/520,136 patent/US9018231B2/en not_active Expired - Fee Related
- 2010-03-24 KR KR1020127020442A patent/KR101463190B1/ko active IP Right Grant
- 2010-03-24 AU AU2010340745A patent/AU2010340745B2/en not_active Ceased
- 2010-03-24 EP EP10725883.2A patent/EP2521714B1/en active Active
- 2010-03-24 SG SG2012048542A patent/SG181992A1/en unknown
- 2010-03-24 DK DK10725883.2T patent/DK2521714T3/en active
- 2010-03-24 ES ES10725883.2T patent/ES2552463T3/es active Active
- 2010-03-24 MX MX2012007783A patent/MX2012007783A/es active IP Right Grant
- 2010-03-24 BR BR112012016526A patent/BR112012016526A2/pt not_active Application Discontinuation
- 2010-03-24 JP JP2012547589A patent/JP5628937B2/ja not_active Expired - Fee Related
-
2012
- 2012-07-01 IL IL220709A patent/IL220709A/en active IP Right Grant
- 2012-07-13 ZA ZA2012/05253A patent/ZA201205253B/en unknown
-
2013
- 2013-04-08 HK HK13104217.4A patent/HK1176619A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2011083487A1 (en) | 2011-07-14 |
EP2521714A1 (en) | 2012-11-14 |
SG181992A1 (en) | 2012-08-30 |
IL220709A (en) | 2015-03-31 |
EA022043B1 (ru) | 2015-10-30 |
US20130005709A1 (en) | 2013-01-03 |
CA2786072C (en) | 2014-10-28 |
NZ601284A (en) | 2014-03-28 |
CA2786072A1 (en) | 2011-07-14 |
KR20120112726A (ko) | 2012-10-11 |
ES2552463T3 (es) | 2015-11-30 |
DK2521714T3 (en) | 2015-10-19 |
EP2521714B1 (en) | 2015-08-12 |
AU2010340745A1 (en) | 2012-08-09 |
BR112012016526A2 (pt) | 2018-11-06 |
KR101463190B1 (ko) | 2014-11-18 |
JP2013516458A (ja) | 2013-05-13 |
CN102869647B (zh) | 2015-06-24 |
MX2012007783A (es) | 2012-10-03 |
AU2010340745B2 (en) | 2014-11-20 |
HK1176619A1 (en) | 2013-08-02 |
CN102869647A (zh) | 2013-01-09 |
ZA201205253B (en) | 2013-05-29 |
IL220709A0 (en) | 2012-08-30 |
JP5628937B2 (ja) | 2014-11-19 |
US9018231B2 (en) | 2015-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023001876A (es) | Derivados de rapamicina. | |
EA201390401A1 (ru) | ПИРАЗИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ENaC БЛОКАТОРОВ | |
EA201490807A1 (ru) | Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1 | |
EA201691302A1 (ru) | Новые гетероциклические соединения | |
EA201390717A1 (ru) | 3-(аминоарил)пиридиновые соединения | |
EA201591239A1 (ru) | Замещенные фталазин-1(2h)-оновые производные в качестве селективных ингибиторов поли(адф-рибоза)полимеразы-1 | |
EA201390766A1 (ru) | БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ | |
EA201070864A1 (ru) | Новые гетероциклические соединения | |
EA201200471A1 (ru) | Простые эфирные производные бициклических гетероарилов | |
MX2012000231A (es) | Nuevos aza-biciclo-hexanos. | |
EA201492170A1 (ru) | Новые замещенные в цикле n-пиридиниламиды в качестве ингибиторов киназ | |
EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
UA109525C2 (xx) | Алкіламідна сполука і її застосування | |
MX353209B (es) | Antagonistas d2, metodos de sintesis y metodos de uso. | |
EA201391056A1 (ru) | Гетероарильные соединения в качестве лигандов 5-htрецептора | |
EA201290582A1 (ru) | ЛИГАНДЫ НЕЙРОНАЛЬНОГО НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА αβ | |
EA201391537A1 (ru) | ЭТИНИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ mGluR5 | |
CY1121147T1 (el) | Νεες συντηγμενες ενωσεις ιμιδαζοβενζοθειαζολιου | |
AU2012245971A8 (en) | A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation | |
WO2012172566A3 (en) | Novel sglt inhibitors | |
EA201270421A1 (ru) | 1,2-дигидро-2-оксохинолиновые соединения в качестве лигандов рецептора 5-нт | |
PH12016500838A1 (en) | Isoxazolines as therapeutic agents | |
EA201290610A1 (ru) | Сульфоновые соединения в качестве лигандов 5-htрецептора | |
EA201001566A1 (ru) | Новый класс спиропиперидинов для лечения нейродегенеративных заболеваний | |
EA201391206A1 (ru) | Способы синтеза производных предшественника молибдоптерина z |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |